A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Thursday 1 October 2009

Losartan: now it's Latvia's turn

SPC enthusiast and expert Alice de Pastors has just told the SPC Blog that, in August of this year, the Latvian Patent Office published a notice regarding the issue of paediatric extension for Losartan. Alice also sent us an extract of page 1135 of Latvian Patent Gazette of 20 August 2009, adding: "The August Latvian Patent Gazette is available here". Thanks so much, Alice!

And if you're wondering what might cause hypertension in laid-back Latvia, here's a selection of tasty recipes, some of which are quite likely to clog up those arteries.

1 comment:

Andreas Schmitt said...

According to the Latvian patent office this is a publication of the APPLICATION for a SPC term extension, not a grant. Also the expiry date given in this publication is the same as of the original SPC.
Andreas Schmitt